Akèy › Limfadenopati Imunoblastik
Etid klinik pou Limfadenopati Imunoblastik ap rekrite nan Etazini
9 etid pou Limfadenopati Imunoblastik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY5 etid
- Durham, NC4 etid
- Houston, TX4 etid
- Chicago, IL4 etid
- Miami, FL4 etid
- Boston, MA3 etid
- Edison, NJ3 etid
- Columbus, OH3 etid
- St. Louis, MO3 etid
- Baldwin Park, CA3 etid
- Atlanta, GA3 etid
- Rochester, MN3 etid
- New Haven, CT3 etid
- Ann Arbor, MI3 etid
Pa eta
- Connecticut3 etid
- Florid4 etid
- Georgia3 etid
- Illinois4 etid
- Kalifòni4 etid
- Maryland3 etid
- Massachusetts3 etid
- Michigan4 etid
- Minnesota3 etid
- Missouri3 etid
- New Jersey4 etid
- New York5 etid
- North Carolina4 etid
- Ohio4 etid
- Pennsylvania4 etid
- Texas4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06561048A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06393738Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT04803201A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Aug 24, 2026 · NCT07055477Registry of Older Patients With Cancer
Ap rekriteEtid obsèvasyon
Laj 65 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT01137825A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT03017820A Registry for People With T-cell Lymphoma
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou May 20, 2026 · NCT05978141Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Oct 27, 2025 · NCT01137643Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2025 · NCT04234048Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.